Rosalia Blanco

1.0k total citations
27 papers, 623 citations indexed

About

Rosalia Blanco is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Epidemiology. According to data from OpenAlex, Rosalia Blanco has authored 27 papers receiving a total of 623 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Cardiology and Cardiovascular Medicine, 5 papers in Internal Medicine and 4 papers in Epidemiology. Recurrent topics in Rosalia Blanco's work include Atrial Fibrillation Management and Outcomes (18 papers), Cardiac Arrhythmias and Treatments (13 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Rosalia Blanco is often cited by papers focused on Atrial Fibrillation Management and Outcomes (18 papers), Cardiac Arrhythmias and Treatments (13 papers) and Cardiac electrophysiology and arrhythmias (5 papers). Rosalia Blanco collaborates with scholars based in United States, United Kingdom and Canada. Rosalia Blanco's co-authors include Gregg C. Fonarow, Eric D. Peterson, Jonathan P. Piccini, Kenneth W. Mahaffey, Daniel E. Singer, Bernard J. Gersh, Peter R. Kowey, Laine Thomas, Alan S. Go and Elaine M. Hylek and has published in prestigious journals such as Circulation, Journal of the American College of Cardiology and Annals of Neurology.

In The Last Decade

Rosalia Blanco

25 papers receiving 617 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rosalia Blanco United States	12	519	169	97	81	38	27	623
Keitaro Senoo Japan	16	714 1.4×	191 1.1×	123 1.3×	43 0.5×	31 0.8×	49	794
S. K. Rushton-Smith United Kingdom	10	670 1.3×	246 1.5×	133 1.4×	61 0.8×	13 0.3×	14	720
Xianying Pan United States	14	922 1.8×	470 2.8×	146 1.5×	122 1.5×	36 0.9×	30	1.1k
Faris Al‐Khalili Sweden	15	1.2k 2.3×	102 0.6×	148 1.5×	120 1.5×	28 0.7×	32	1.3k
Annya Stephens-Boal United Kingdom	3	451 0.9×	232 1.4×	95 1.0×	85 1.0×	14 0.4×	9	543
Gregory Lip United Kingdom	7	580 1.1×	172 1.0×	127 1.3×	43 0.5×	25 0.7×	12	649
Chern En Chiang Taiwan	3	650 1.3×	299 1.8×	116 1.2×	40 0.5×	23 0.6×	4	726
Annette Lemche Gulløv Denmark	5	528 1.0×	253 1.5×	133 1.4×	46 0.6×	34 0.9×	7	589
Birgitte Gade Koefoed Denmark	9	428 0.8×	234 1.4×	132 1.4×	35 0.4×	33 0.9×	16	569
Kori Leblanc Canada	9	524 1.0×	172 1.0×	94 1.0×	121 1.5×	25 0.7×	33	748

Countries citing papers authored by Rosalia Blanco

Since Specialization

Citations

This map shows the geographic impact of Rosalia Blanco's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rosalia Blanco with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rosalia Blanco more than expected).

Fields of papers citing papers by Rosalia Blanco

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rosalia Blanco. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rosalia Blanco. The network helps show where Rosalia Blanco may publish in the future.

Co-authorship network of co-authors of Rosalia Blanco

This figure shows the co-authorship network connecting the top 25 collaborators of Rosalia Blanco. A scholar is included among the top collaborators of Rosalia Blanco based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rosalia Blanco. Rosalia Blanco is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Jacobs, Joshua A., Adam P. Bress, Madeline R. Sterling, et al.. (2024). Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure. Circulation Heart Failure. 18(1). e012357–e012357. 3 indexed citations

Jacobs, Joshua A., Adam P. Bress, Madeline R. Sterling, et al.. (2024). Abstract 4139436: Social Determinants of Health and Disparities in Guideline-Directed Medical Therapy Optimization for Heart Failure. Circulation. 150(Suppl_1).

Blanco, Rosalia. (2024). First steps to create a data-driven culture in organizations. Case study in a financial institution.. 1–6.

Raychev, Radoslav, Jie‐Lena Sun, Lee H. Schwamm, et al.. (2023). Performance of Thrombectomy-Capable, Comprehensive, and Primary Stroke Centers in Reperfusion Therapies for Acute Ischemic Stroke: Report From the Get With The Guidelines–Stroke Registry. Circulation. 148(25). 2019–2028. 11 indexed citations

Shah, Nishant, Eric D. Peterson, Courtney Page, Rosalia Blanco, & Ann Marie Návar. (2023). Generalizability of an EHR-network dataset to the United States for cardiovascular disease conditions: Comparison of Cerner real world data with the national inpatient sample. American Heart Journal. 263. 64–72. 1 indexed citations

Nogueira, Raul G., Diogo C Haussen, Eric E. Smith, et al.. (2023). Higher Procedural Volumes Are Associated with Faster Treatment Times, Better Functional Outcomes, and Lower Mortality in Patients Undergoing Endovascular Treatment for Acute Ischemic Stroke. Annals of Neurology. 95(1). 146–155. 6 indexed citations

Carlisle, Matthew A., Peter Shrader, Marat Fudim, et al.. (2022). Residual stroke risk despite oral anticoagulation in patients with atrial fibrillation. Heart Rhythm O2. 3(6). 621–628. 3 indexed citations

Jackson, Larry R., Laine Thomas, Benjamin A. Steinberg, et al.. (2021). Dosing of Direct Oral Anticoagulants in Patients with Moderate Chronic Kidney Disease in US Clinical Practice: Results from the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF II). American Journal of Cardiovascular Drugs. 21(5). 553–561. 8 indexed citations

Jackson, Larry R., Sunghee Kim, Rosalia Blanco, et al.. (2020). Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II). American Heart Journal. 226. 85–93. 14 indexed citations

10.

Sherwood, Matthew W., Jonathan P. Piccini, DaJuanicia N. Holmes, et al.. (2020). Outcomes of Cardiac Catheterization in Patients With Atrial Fibrillation on Anticoagulation in Contemporary in Practice. Circulation Cardiovascular Interventions. 13(5). e008274–e008274. 1 indexed citations

11.

Inohara, Taku, Peter Shrader, Karen S. Pieper, et al.. (2019). Treatment of atrial fibrillation with concomitant coronary or peripheral artery disease: Results from the outcomes registry for better informed treatment of atrial fibrillation II. American Heart Journal. 213. 81–90. 9 indexed citations

12.

Loring, Zak, Peter Shrader, Larry A. Allen, et al.. (2019). Guideline-directed therapies for comorbidities and clinical outcomes among individuals with atrial fibrillation. American Heart Journal. 219. 21–30. 12 indexed citations

13.

Jackson, Larry R., Sunghee Kim, Peter Shrader, et al.. (2018). Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. Journal of Thrombosis and Thrombolysis. 46(4). 435–439. 8 indexed citations

14.

Holmes, DaJuanicia N., Marwan Badri, Karen S. Pieper, et al.. (2018). Embolic and Other Adverse Outcomes in Symptomatic Versus Asymptomatic Patients With Atrial Fibrillation (from the ORBIT-AF Registry). The American Journal of Cardiology. 122(10). 1677–1683. 13 indexed citations

15.

Essien, Utibe R., DaJuanicia N. Holmes, Larry R. Jackson, et al.. (2018). Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial Fibrillation. JAMA Cardiology. 3(12). 1174–1174. 107 indexed citations

16.

Fudim, Marat, Peter Shrader, Rosalia Blanco, et al.. (2018). Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT‐AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry. Journal of the American Heart Association. 7(8). 6 indexed citations

17.

Pokorney, Sean D., DaJuanicia N. Simon, Laine Thomas, et al.. (2015). Patients’ time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry. American Heart Journal. 170(1). 141–148.e1. 171 indexed citations

18.

Pokorney, Sean D., DaJuanicia N. Simon, Laine Thomas, et al.. (2015). THE MYTH OF THE STABLE INR PATIENT: RESULTS FROM ORBIT-AF. Journal of the American College of Cardiology. 65(10). A344–A344. 4 indexed citations

19.

Steinberg, Benjamin A., Rosalia Blanco, Sunghee Kim, et al.. (2014). Outcomes registry for better informed treatment of atrial fibrillation II: Rationale and design of the ORBIT-AF II registry. American Heart Journal. 168(2). 160–167. 53 indexed citations

20.

Blanco, Rosalia, et al.. (2009). [Tuberculous peritonitis in peritoneal dialysis].. PubMed. 29(2). 170–2. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact